Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Andreas Wollenberg | Researchclopedia

Back to researchers

Andreas Wollenberg

Vrije Universiteit Brussel ORCID

574

Works

28,407

Citations

79

h-index

272

i10-index

Research Topics

Dermatology and Skin Diseases Allergic Rhinitis and Sensitization Food Allergy and Anaphylaxis Research

Affiliations

Augsburg University2024–2024

Oxfam2019–2020

Hudson Institute2019–2020

Vrije Universiteit Brussel2022–2025

University of Augsburg2024–2024

Top Works

Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis

Eric L. Simpson,Thomas Bieber,et al.

20161,990 citations

Asthma and respiratory diseases

Urticaria and Related Conditions

Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I

Andreas Wollenberg,S. Barbarot,et al.

20181,152 citations

Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II

Andreas Wollenberg,S. Barbarot,et al.

2018681 citations

Guidelines for treatment of atopic eczema (atopic dermatitis) Part I

Johannes Ring,A. Alomar,et al.

2012680 citations

Cellular and molecular immunologic mechanisms in patients with atopic dermatitis

Thomas Werfel,Jean‐Pierre Allam,et al.

2016579 citations

Anti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis

Thomas Ruzicka,Jon M. Hanifin,et al.

2017576 citations

Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*

Andreas Wollenberg,Andrew Blauvelt,et al.

2020564 citations

Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (Fc epsilon RI).

T Bieber,Henri de la Salle,et al.

1992489 citations

Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Eric L. Simpson,Rodney Sinclair,et al.

2020461 citations